201 related articles for article (PubMed ID: 26147011)
21. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test.
Gould TD; Einat H; Bhat R; Manji HK
Int J Neuropsychopharmacol; 2004 Dec; 7(4):387-90. PubMed ID: 15315719
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and ex vivo evaluation of carbon-11 labelled N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea ([11C]AR-A014418): a radiolabelled glycogen synthase kinase-3beta specific inhibitor for PET studies.
Vasdev N; Garcia A; Stableford WT; Young AB; Meyer JH; Houle S; Wilson AA
Bioorg Med Chem Lett; 2005 Dec; 15(23):5270-3. PubMed ID: 16202587
[TBL] [Abstract][Full Text] [Related]
23. Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418.
Bhat R; Xue Y; Berg S; Hellberg S; Ormö M; Nilsson Y; Radesäter AC; Jerning E; Markgren PO; Borgegård T; Nylöf M; Giménez-Cassina A; Hernández F; Lucas JJ; Díaz-Nido J; Avila J
J Biol Chem; 2003 Nov; 278(46):45937-45. PubMed ID: 12928438
[TBL] [Abstract][Full Text] [Related]
24. Identification of glycogen synthase kinase 3α as a therapeutic target in melanoma.
Madhunapantula SV; Sharma A; Gowda R; Robertson GP
Pigment Cell Melanoma Res; 2013 Nov; 26(6):886-99. PubMed ID: 24034838
[TBL] [Abstract][Full Text] [Related]
25. ZM336372 induces apoptosis associated with phosphorylation of GSK-3beta in pancreatic adenocarcinoma cell lines.
Deming D; Geiger P; Chen H; Kunnimalaiyaan M; Holen K
J Surg Res; 2010 Jun; 161(1):28-32. PubMed ID: 20031160
[TBL] [Abstract][Full Text] [Related]
26. Glycogen synthase kinase 3-specific inhibitor AR-A014418 decreases neuropathic pain in mice: evidence for the mechanisms of action.
Mazzardo-Martins L; Martins DF; Stramosk J; Cidral-Filho FJ; Santos AR
Neuroscience; 2012 Dec; 226():411-20. PubMed ID: 23000630
[TBL] [Abstract][Full Text] [Related]
27. Anti-stress effects of a GSK-3β inhibitor, AR-A014418, in immobilization stress of variable duration in mice.
Bali A; Jaggi AS
J Basic Clin Physiol Pharmacol; 2017 Jul; 28(4):315-325. PubMed ID: 28590916
[TBL] [Abstract][Full Text] [Related]
28. Towards the preparation of radiolabeled 1-aryl-3-benzyl ureas: Radiosynthesis of [(11)C-carbonyl] AR-A014418 by [(11)C]CO(2) fixation.
Hicks JW; Wilson AA; Rubie EA; Woodgett JR; Houle S; Vasdev N
Bioorg Med Chem Lett; 2012 Mar; 22(5):2099-101. PubMed ID: 22321216
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice.
Rosa AO; Kaster MP; Binfaré RW; Morales S; Martín-Aparicio E; Navarro-Rico ML; Martinez A; Medina M; García AG; López MG; Rodrigues AL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1549-56. PubMed ID: 18579278
[TBL] [Abstract][Full Text] [Related]
30. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
31. Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.
Darrington RS; Campa VM; Walker MM; Bengoa-Vergniory N; Gorrono-Etxebarria I; Uysal-Onganer P; Kawano Y; Waxman J; Kypta RM
Int J Cancer; 2012 Sep; 131(6):E872-83. PubMed ID: 22539113
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glycogen synthase kinase-3beta promotes nuclear export of the androgen receptor through a CRM1-dependent mechanism in prostate cancer cell lines.
Schütz SV; Cronauer MV; Rinnab L
J Cell Biochem; 2010 Apr; 109(6):1192-200. PubMed ID: 20127713
[TBL] [Abstract][Full Text] [Related]
33. Antiproliferative and apoptotic effect of LY2090314, a GSK-3 inhibitor, in neuroblastoma in vitro.
Kunnimalaiyaan S; Schwartz VK; Jackson IA; Clark Gamblin T; Kunnimalaiyaan M
BMC Cancer; 2018 May; 18(1):560. PubMed ID: 29751783
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms.
Marchand B; Tremblay I; Cagnol S; Boucher MJ
Carcinogenesis; 2012 Mar; 33(3):529-37. PubMed ID: 22201186
[TBL] [Abstract][Full Text] [Related]
35. Curcumin-mediated regulation of Notch1/hairy and enhancer of split-1/survivin: molecular targeting in cholangiocarcinoma.
Koprowski S; Sokolowski K; Kunnimalaiyaan S; Gamblin TC; Kunnimalaiyaan M
J Surg Res; 2015 Oct; 198(2):434-40. PubMed ID: 25890434
[TBL] [Abstract][Full Text] [Related]
36. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
[TBL] [Abstract][Full Text] [Related]
37. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
Zhong W; Darmani NA
Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
[TBL] [Abstract][Full Text] [Related]
38. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
39. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
40. Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles.
Ristorcelli E; Beraud E; Mathieu S; Lombardo D; Verine A
Int J Cancer; 2009 Sep; 125(5):1016-26. PubMed ID: 19405120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]